Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Other Non-Current Assets: 2022-2024

Historic Other Non-Current Assets for Immunocore Holdings (IMCR) over the last 3 years, with Dec 2024 value amounting to $17.1 million.

  • Immunocore Holdings' Other Non-Current Assets fell 4.35% to $16.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.5 million, marking a year-over-year decrease of 4.35%. This contributed to the annual value of $17.1 million for FY2024, which is 18.27% up from last year.
  • According to the latest figures from FY2024, Immunocore Holdings' Other Non-Current Assets is $17.1 million, which was up 18.27% from $14.5 million recorded in FY2023.
  • In the past 5 years, Immunocore Holdings' Other Non-Current Assets registered a high of $17.1 million during FY2024, and its lowest value of $8.9 million during FY2022.
  • Moreover, its 3-year median value for Other Non-Current Assets was $14.5 million (2023), whereas its average is $13.5 million.
  • Data for Immunocore Holdings' Other Non-Current Assets shows a peak YoY skyrocketed of 62.86% (in 2023) over the last 5 years.
  • Over the past 3 years, Immunocore Holdings' Other Non-Current Assets (Yearly) stood at $8.9 million in 2022, then skyrocketed by 62.86% to $14.5 million in 2023, then grew by 18.27% to $17.1 million in 2024.